I help life-science teams de-risk emerging-market trials through governance-aligned feasibility and responsible activation.

Current Work

Kind Shark

We help life-science teams figure out if Indonesia will work for your trial—fast, safely, and under Ministry rules—before you spend big.

Feasibility signals you can trust: privacy-safe patient counts and patterns turned into planning-ready answers.
Sites you can actually run with: identify + qualify the right hospitals, investigators, labs/imaging, and local operators.
Enrollment pathways that are compliant: practical recruitment routes through approved channels (sites + trusted partners), no raw data exposure.

Strategic Advisory

I advise large foundations, global family offices, and mission-driven institutions on how to deploy capital and build partnerships that actually work—especially where sovereignty and governance shape what’s possible.

Make big bets executable: turn mission into a crisp strategy, pipeline, and decision criteria.
Structure it defensibly: cross-border setup + partner design that reduces risk, friction, and reputational exposure.
Operate with governments smoothly: stakeholder alignment so programs can launch, scale, and stay trusted.

Dr. Diane Gu

Dr. Diane Gu is the Founder & CEO of Kind Shark—an AI-enabled clinical research partner supporting trial readiness and responsible activation in emerging markets.

Her work focuses on a single outcome: helping sponsors determine whether, where, and under what governance conditions a market should advance—using privacy-preserving feasibility signals and on-the-ground activation pathways (sites, investigators, labs, operational partners, and compliant recruitment enablement).

Dr. Gu’s career spans global health philanthropy, academic research, and sovereign health system collaboration. She has worked alongside national health authorities and philanthropic institutions connected to the Gates Foundation, and has held academic affiliations with University of Washington and University of California, Los Angeles.

Her approach integrates governance alignment, operational reality, and disciplined advancement criteria—so emerging-market expansion is decision-ready, defensible, and executable.

Selected Writing

Chinese Dreams? American Dreams?

Dr. Gu is the author of Chinese Dreams? American Dreams? (Springer), an ethnographic study of professional pathways and institutional environments among immigrant scientists and engineers.

The systems-oriented perspective of this work informs her current focus on structural readiness and governance-aligned development strategy.